Wyeth Investors Win Class Cert. In Suit Over Pristiq Risks
A New York federal judge on Tuesday granted class certification to a group of investors accusing Pfizer Inc. unit Wyeth Pharmaceuticals Inc. of failing to disclose serious side effects associated with...To view the full article, register now.
Already a subscriber? Click here to view full article